ARENSIA Exploratory Medicine is a privately owned company specialized in the performance of early clinical trials in patients: Phase I/Ib/IIa and PROOF OF CONCEPT, conducted in hospital based clinical pharmacology units in Eastern Europe.

RECRUITMENT SPEED AND CAPABILITY MAKE US UNIQUE!

ARENSIA brings together large patient populations, incl. treatment naïve, with year long know-how in exploratory clinical trials. The combination of resources and skills is highly potent: we are able to conduct the most complex studies, in patients, in a Phase I set-up.

The company has strategic, exclusive partnerships with reputable university and clinical hospitals in Romania, Republic of Moldova and Lithuania for exploratory development projects.

• 3 PHASE I UNITS IN BUCHAREST, ROMANIA

• 2 PHASE I UNITS IN CHISINAU, MOLDOVA

• 1 PHASE I UNIT IN VILNIUS, LITHUANIA

Our units serve following therpeutic areas:
immuno-inflammatory, cardiovascular, diabetes/metabolic, respiratory, hepatology, nephrology, gastroenterology, infectious diseases HCV/HIV, urology, oncology, dermatology, neurology, psychiatry

ARENSIA has expertise to perform sophisticated designs and clinical investigations within a scientific environment: intensive PK and PD schedules, long hospitalization, invasive and non-invasive techniques.

Latest imaging technology is available e.g. MRI, CT, PET, etc.

The timelines for regulatory approval are reliable and competitive:
4 weeks for Moldova and 8 weeks for Romania and Lithuania.

ARENSIA has repeat business with the major international Sponsors.

ARENSIA - YOUR RELIABLE PARTNER FOR PROOF OF CONCEPT/EARLY PATIENT STUDIES!